Details
| Stereochemistry | RACEMIC |
| Molecular Formula | 2C10H13N3O2.H2O4S |
| Molecular Weight | 512.537 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.NC(=N)NCC1COC2=CC=CC=C2O1.NC(=N)NCC3COC4=CC=CC=C4O3
InChI
InChIKey=NSGHAKPGHCNTPS-UHFFFAOYSA-N
InChI=1S/2C10H13N3O2.H2O4S/c2*11-10(12)13-5-7-6-14-8-3-1-2-4-9(8)15-7;1-5(2,3)4/h2*1-4,7H,5-6H2,(H4,11,12,13);(H2,1,2,3,4)
| Molecular Formula | H2O4S |
| Molecular Weight | 98.078 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C10H13N3O2 |
| Molecular Weight | 207.2291 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14147778
The drug may be given orally initially
at a dose of 20 mg. daily and doubled every fourth day until an effect is obtained. Where more rapid effect is desired, a loading dose of 40 mg. may be used.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:45:24 GMT 2025
by
admin
on
Mon Mar 31 17:45:24 GMT 2025
|
| Record UNII |
N6IT80R85G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000086696
Created by
admin on Mon Mar 31 17:45:24 GMT 2025 , Edited by admin on Mon Mar 31 17:45:24 GMT 2025
|
PRIMARY | |||
|
m5873
Created by
admin on Mon Mar 31 17:45:24 GMT 2025 , Edited by admin on Mon Mar 31 17:45:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
N6IT80R85G
Created by
admin on Mon Mar 31 17:45:24 GMT 2025 , Edited by admin on Mon Mar 31 17:45:24 GMT 2025
|
PRIMARY | |||
|
SUB02432MIG
Created by
admin on Mon Mar 31 17:45:24 GMT 2025 , Edited by admin on Mon Mar 31 17:45:24 GMT 2025
|
PRIMARY | |||
|
C174743
Created by
admin on Mon Mar 31 17:45:24 GMT 2025 , Edited by admin on Mon Mar 31 17:45:24 GMT 2025
|
PRIMARY | |||
|
108162
Created by
admin on Mon Mar 31 17:45:24 GMT 2025 , Edited by admin on Mon Mar 31 17:45:24 GMT 2025
|
PRIMARY | |||
|
CHEMBL76725
Created by
admin on Mon Mar 31 17:45:24 GMT 2025 , Edited by admin on Mon Mar 31 17:45:24 GMT 2025
|
PRIMARY | |||
|
23724918
Created by
admin on Mon Mar 31 17:45:24 GMT 2025 , Edited by admin on Mon Mar 31 17:45:24 GMT 2025
|
PRIMARY | |||
|
DBSALT002676
Created by
admin on Mon Mar 31 17:45:24 GMT 2025 , Edited by admin on Mon Mar 31 17:45:24 GMT 2025
|
PRIMARY | |||
|
5714-04-5
Created by
admin on Mon Mar 31 17:45:24 GMT 2025 , Edited by admin on Mon Mar 31 17:45:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |